Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Rubio-Rivas

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
European Journal of Internal Medicine|April 26, 2020
Clinical phenotypes and prediction of chronicity in sarcoidosis using cluster analysis in a prospective cohort of 694 patientsManuel Rubio-Rivas, Xavier Corbella
Revista Clinica Espanola|February 22, 2024
Prevalence of the limited vs. extensive scleroderma-related interstitial lung disease at the time of diagnosis of SSc-ILD based on Goh et al. criteria. Systematic review and meta-analysisManuel Rubio-Rivas, Melani Pestaña-Fernández
Respiratory Medicine|May 27, 2019
Elderly sarcoidosis: A comparative study from a 42-year single-centre experienceManuel Rubio-Rivas, Xavier Corbella, Juan Mañá
Joint Bone Spine|October 14, 2019
Sarcoidosis presenting with and without Löfgren's syndrome: Clinical, radiological and behavioral differences observed in a group of 691patientsManuel Rubio-Rivas, Jonathan Franco, Xavier Corbella
Autoimmunity Reviews|June 20, 2020
Sarcoidosis related to checkpoint and BRAF/MEK inhibitors in melanomaManuel Rubio-Rivas, Catarina Moreira, J Marcoval
Clinical Rheumatology|January 17, 2017
Occupational and environmental scleroderma. Systematic review and meta-analysisManuel Rubio-Rivas, Rafael Moreno, Xavier Corbella
Autoimmunity Reviews|November 16, 2020
The prevalence and incidence rate of pulmonary arterial hypertension in systemic sclerosis: Systematic review and meta-analysisManuel Rubio-Rivas, Narcís A Homs, Daniel Cuartero, et al.
Respiratory Medicine|May 23, 2020
Clinical features and outcomes of asymptomatic pulmonary sarcoidosis. A comparative cohort studyAdriana Iriarte, Manuel Rubio-Rivas, Nadia Villalba, et al.
Medicina (Kaunas, Lithuania)|February 26, 2025
Should the Start of Immunosuppressive Treatment for COVID-19 Rely upon the Degree of Inflammation or the Time from Onset?José María Mora-Luján, Abelardo Montero, Francesc Formiga, et al.
Seminars in Arthritis and Rheumatism|June 17, 2014
Mortality and survival in systemic sclerosis: systematic review and meta-analysisManuel Rubio-Rivas, Cristina Royo, Carmen Pilar Simeón, et al.
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
European Journal of Internal Medicine|April 26, 2020
Clinical phenotypes and prediction of chronicity in sarcoidosis using cluster analysis in a prospective cohort of 694 patientsManuel Rubio-Rivas, Xavier Corbella
Revista Clinica Espanola|February 22, 2024
Prevalence of the limited vs. extensive scleroderma-related interstitial lung disease at the time of diagnosis of SSc-ILD based on Goh et al. criteria. Systematic review and meta-analysisManuel Rubio-Rivas, Melani Pestaña-Fernández
Respiratory Medicine|May 27, 2019
Elderly sarcoidosis: A comparative study from a 42-year single-centre experienceManuel Rubio-Rivas, Xavier Corbella, Juan Mañá
Joint Bone Spine|October 14, 2019
Sarcoidosis presenting with and without Löfgren's syndrome: Clinical, radiological and behavioral differences observed in a group of 691patientsManuel Rubio-Rivas, Jonathan Franco, Xavier Corbella
Autoimmunity Reviews|June 20, 2020
Sarcoidosis related to checkpoint and BRAF/MEK inhibitors in melanomaManuel Rubio-Rivas, Catarina Moreira, J Marcoval
Clinical Rheumatology|January 17, 2017
Occupational and environmental scleroderma. Systematic review and meta-analysisManuel Rubio-Rivas, Rafael Moreno, Xavier Corbella
Autoimmunity Reviews|November 16, 2020
The prevalence and incidence rate of pulmonary arterial hypertension in systemic sclerosis: Systematic review and meta-analysisManuel Rubio-Rivas, Narcís A Homs, Daniel Cuartero, et al.
Respiratory Medicine|May 23, 2020
Clinical features and outcomes of asymptomatic pulmonary sarcoidosis. A comparative cohort studyAdriana Iriarte, Manuel Rubio-Rivas, Nadia Villalba, et al.
Medicina (Kaunas, Lithuania)|February 26, 2025
Should the Start of Immunosuppressive Treatment for COVID-19 Rely upon the Degree of Inflammation or the Time from Onset?José María Mora-Luján, Abelardo Montero, Francesc Formiga, et al.
Seminars in Arthritis and Rheumatism|June 17, 2014
Mortality and survival in systemic sclerosis: systematic review and meta-analysisManuel Rubio-Rivas, Cristina Royo, Carmen Pilar Simeón, et al.
Pageof 9